Morteza Nadjafi, MD, FAPA

Orlando, Florida 32803

0 studies enrolling now · 1 studies all time

What they study most

Attention-Deficit/Hyperactivity Disorder

Studies at this site

• Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl — Completed